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erbation of renal tubule ultrastructure injury and greater activation of Akt
and ERK1/2 phosphorylated signaling. Conversely, treatment with hrACE2
signiﬁcantly attenuated renal oxidative stress levels and ultrastructure
injury, and prevented the expression of NOX4 and phosphorylated level
of Akt and ERK1/2 in ApoEKO mouse kidneys. However, there were no
changes in renal expression of NOX2 among groups.
CONCLUSIONS Deletion of ACE2 triggers greater increases in renal
oxidative stress and tubular ultrastructure injury in the ACE2/ApoE
double mutant mice with greater activation of Akt-ERK1/2 phos-
phorylated signaling. While ACE2 overexpression alleviates renal
tubular injury in ApoE-mutant mice with suppression of superoxide
generation and downregulation of the Akt-ERK phosphorylated
signaling. Strategies aimed at enhancing ACE2 action may have
important therapeutic potential for atherosclerosis and renal diseases.
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OBJECTIVES Genetic predisposition plays an important role amidst
the other risk factors in the development of atherosclerosis, a socially
signiﬁcant multifactorial disease. This study was aimed to identify
the relationship between mitochondrial DNA (mtDNA) variants and
the presence of subclinical atherosclerosis, which was deﬁned ultra-
sonographically as the abnormal increase of intima-media thickness of
common carotid arteries (cIMT).
METHODS For the accurate detection of mtDNA variants, high-
throughput sequencing of the mitochondrial genome from blood
leukocytes using the Roche 454 technology was carried out in 77
asymptomatic non-related subjects. To assess the state of the carotid
artery wall, high-resolution B-mode ultrasonography was performed
with ultrasound scanner SonoScape SSI-1000 (China) using a linear
vascular 7.5 MHz probe. The borderline values for Russian population
were used for detection of abnormal cIMT values.
RESULTS In patients with subclinical atherosclerosis, 70 mtDNA
variants have been revealed that were characterized by the prevalence
over 5% of the total sample or among patients or controls. Twenty-ﬁve
of them occurred in coding region, and 5 were located in rRNA genes,
3 in tRNA genes, 5 were missense mutations. For 5 variants charac-
terized by the increased frequency in healthy subjects there were
signiﬁcant differences from the patients with subclinical atheroscle-
rosis. Three homoplasmic mtDNA variants were found only in patients
with atherosclerosis. Six MtDNA variants were characterized by a
more than 2-fold increased frequency in patients with subclinical
atherosclerosis as compared to healthy subjects. As for 115 hetero-
plasmic mtDNA variants revealed, 15 were found both in healthy
subjects and patients with subclinical carotid atherosclerosis. Three
variants had higher frequency in healthy subjects, and two variants
had higher frequency in patients with subclinical atherosclerosis.
CONCLUSIONS The data obtained in our study can be used to assess
individual risk of atherosclerosis and for further studies on the role of
mitochondrial genome mutations in the development of atheroscle-
rosis and its clinical manifestations. The individual proﬁle of certain
mtDNA variants may partially explain atherosclerosis variability and
genetic predisposition to atherosclerosis in population, which could
be inherited by maternal line.
This study was supported by Russian Scientiﬁc Foundation, Grant
No. 14-14-01038.
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OBJECTIVES Long non-coding RNAs (lncRNAs) have been found to be
involved in coronary artery disease (CAD) development. Whether ornot circulating lncRNAs work as a CAD biomarker, needs to be
established.
METHODS Using microarray-based lncRNA expression proﬁling to
explore the lncRNA expression in the circulating peripheral blood
monocyte (PBMCs) and plasma from 15 CAD patients and 15 control
subjects. After criteria (average normalized intensity is more than 7
with signiﬁcance less than 0.005) based selection, and conﬁrmed by
quantitative RT-PCR. Using the analysis of the area under the curve
(AUC) of the receiver operating characteristic (ROC) in large amount of
population. Functional enrichment analysis was performed by GO and
pathway analysis. Further validation using the speciﬁc siRNA in the
THP-1 cell line, and the concentrations of pro-inﬂammatory cytokines
(IL-1b, IL-6 and TNFa) in the culture media, were studied by ELISA.
RESULTS According to the array in the PBMCs and plasma, we found
86 lncRNAs that were differentially expressed in both PBMCs and
plasma from 15 CAD patients and 15 control subjects. After criteria and
conﬁrmed by quantitative RT-PCR, only three lncRNAs (CoroMarker,
BAT5 and IL21R-AS1) remained in the select candidate list. By ROC
analysis, CoroMarker was found to be the best candidate biomarker
for CAD with an AUC of 0.920, 95% CI 0.892-0.947. CoroMarker was
independent from CAD risk factors and other cardiovascular diseases.
In a prospective study, we found the sensitivity and speciﬁcity of
CoroMarker were 76% and 92.5%, respectively. Functional enrichment
analysis showed CoroMarker being clustered with small molecule
metabolic process and the signal transduction signaling pathway.
Further validation using the speciﬁc siRNA in the THP-1 cell line, the
concentrations of pro-inﬂammatory cytokines (IL-1b, IL-6 and TNFa)
in the culture media, were reduced signiﬁcantly.
CONCLUSIONS The present study suggests that CoroMarker have an
unanticipated role in inﬂammatory response to ﬁnally impact in the
risk of CAD, and be a novel and speciﬁc functional biomarker for the
diagnosis of CAD.GW26-e1064
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OBJECTIVES Our previous study conﬁrmed that in heart failure the
expression and function of SK channels upregulated signiﬁcantly and
participated in electrical remodeling of cardiocytes, but the regulation
of SK channels was poorly understood in this process. Studies indi-
cated that the sensitivity of SK channels to [Ca2þ]i is positively
regulated by PP2A, which is activated by angiotensin II in many bio-
logical response paths. In the present study, we explored the effect of
angiotensin converting enzyme inhibitor captopril on apamin sensi-
tive SK channels in HF.
METHODS We used volume-overload induced heart failure rat model
by aortocaval ﬁstulas (HF group), and captopril was administrated by
gavage (CAF group). Whole-cell patch clamp was performed to
recording IKAS (Apamin sensitive current), and I-V curve was applied
to determine the the effect of captopril on IKAS. We also explored the
effect of captopril on the sensitivety of SK channels to [Ca2þ]i by
setting various [Ca2þ]i (10, 100, 500, 900,10,000 nM) at single isolated
cells, and the Hill equation (y¼1/[1þ (EC50/x)n]) was employed to
ﬁtted currents data(EC50 represents the [Ca2þ]i concentration at
halfmaximal activation of IKAS, n represents the Hill coefﬁcient). And
immunoﬂuorescent staining, real time PCR, western blot were also
carried out to furtherly investigate the underlying molecular mecha-
nism of the regulation.
RESULTS Captopril signiﬁcantly decreased the mean IKAS density at
0 mV (CAF 5.40  1.11 pA/pF, n ¼ 6 cells from 5 rats vs HF 8.90  1.79
pA/pF, n ¼ 5 cells from 6 rats P<0.05) when [Ca2þ]i at 900 nM
comparing with HF group, and obviously shifted down the I-V curve.
Similarly, the IKAS density was markedly downregulated by captopril
when [Ca2þ]i at 500, 1000, 10000nM (500 nM: CAF 4.21  0.16 pA/pF,
n ¼ 6 cells from 4 rats vs HF 7.98  0.43 pA/pF, n ¼ 6 cells from 6 rats
P<0.05; 1000nM: CAF 5.51  0.71 pA/pF, n ¼ 6 cells from 6 rats vs HF
8.96  0.51 pA/pF, n ¼ 6 cells from 5 rats P<0.05; 10000nM: CAF 5.80
 0.52 pA/pF, n ¼ 5 cells from 3 rats vs HF 9.02  0.57 pA/pF, n ¼ 5
cells from 4 rats P<0.05), the data of the Hill ﬁtting showed the sig-
niﬁcant difference in EC50 values and the Hill coefﬁcients among
the three group cells (EC50 CAF 313  17 nM, HF 231  11 nM, P<0.05;
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the results of real time PCR and western blot demonstrated that
captopril signiﬁcantly downregulated the expression of apamin sen-
sitive SK channels (SK3 mRNA: CAF 2.10  0.9, n ¼ 6 vs HF 8.40  2.10,
n ¼ 6; SK3 protein: CAF 0.40  0.07, n ¼ 6 vs HF 0.56  0.09, n ¼ 6).
CONCLUSIONS Captopril signiﬁcantly downregulated the sensitivity
of SK channels to [Ca2þ]i and the SK3 channels expression in HF, and
reversed the SK channels remodeling.GW26-e1586
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OBJECTIVES AMP-activated protein kinase (AMPK) exerts inhibitory
effects on cardiac hypertrophy. However, the mechanism remains
unclear. The aim of the present study was to investigate the effects of
AMPK on angiotensin II (AngII) -induced proliferation of cardiac
ﬁbroblast and the mechanisms involved.
METHODS Proliferation of cardiac ﬁbroblast was induced by angio-
tensin II (AngII). Cardiac ﬁbroblasts were treated with the speciﬁc
AMPK activator 5-aminoimidazole-4-carboxamide ribonucleoside
(AICAR, 0.5 mmol/L) and the speciﬁc AMPK antagonist Compound C
(1 umol/L), and then stimulated with AngII (1 umol/L). Cell prolifera-
tion and the DNA synthesis were measured by MTT assay and EdU
incorporation assay. TGF-b1 and Smad2, 3, 4 mRNA and protein
expression was detected using Real-Time PCR and western blot
analysis.
RESULTS Activation of AMPK by AICAR could inhibit AngII-induced
proliferation of cardiac ﬁbroblasts, manifesting decreased DNA syn-
thesis and collagen production (P<0.05). Moreover, AngII signiﬁ-
cantly increased the mRNA and protein expression of TGF-b1 and
Smad2, 3, 4 (P<0.05). AMPK activation markedly reversed the
elevated TGF-b1 and Smad2, 3, 4 mRNA and protein levels (P<0.05).
Furthermore, Treatment of proliferated cardiac ﬁbroblasts with
Compound C blunted the effects of AMPK on proliferation of cardiac
ﬁbroblasts and changes to the TGF-b1/Smad pathway (P<0.05).
CONCLUSIONS AMPK activation could attenuate proliferation of
cardiac ﬁbroblast induced by AngII, which may be due to the inhibi-
tion of TGF-b1/Smad pathways.GW26-e4768
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OBJECTIVES Depressed angiogenesis due to ischemic injury leads to
myocardial infarction. Copper (Cu) is involved in angiogenesis and
ischemia causes copper loss in the heart. The present study was un-
dertaken to test the hypothesis that Cu supplementation improves
myocardial angiogenesis, leading to regression of myocardial ischemic
infarction in Rhesus monkey model.
METHODS Coronary artery ligation was used to produce myocardial
ischemia and the monkeys developed myocardial infarction 4 weeks
after ischemia. A newly developed ultrasound contrast microbubble
composed of Cu-albumin coated structure was used to speciﬁcally
deliver Cu into the infarct area. The treatment was performed twice a
week for 4 weeks.
RESULTS This procedure effectively increased Cu concentrations in
the infarct area and activated the angiogenesis factors including
vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR-1),
and other relevant factors. Along with these changes, myocardial
infarct size was signiﬁcantly decreased and the density of myocardial
microvessels was signiﬁcantly increased. In addition, cardiac function
was signiﬁcantly recovered, as evidenced by increased ejection fraction
(EF) values and decreased end-systolic volume (ESV) measured by
echocardiography.CONCLUSIONS This study thus demonstrated that Cu supplementa-
tion improved cardiac structural and functional recovery after
ischemic infarction.
Supported by National Science Foundation of China (81230004 and
81300109).
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OBJECTIVES The atrioventricular node(AVN) plays a role in conducting
action potentials at an appropriate conduction velocity from atria to
ventricles. Its complex anatomical structures and functional longitudi-
nal dissociations are considered important in delayed conduction and
AVN reentrant tachycardia (AVNRT). Inferior nodal extensions(INE) are
part of the AVN. It is thought that these extensions may be involved in
slow-pathway conduction and are part of the underlying circuitry that
causes AVNRT. Some other conduction tissue shared the same origin
layers with AVN distribute around the two valve annulus. The retro-
aortic node deﬁned as the enlargement of this node-like tissue is located
on the right side of the atrium parallel with the aorta. The potential
electrophysiological function of these node-like tissues is still unknown.
Understanding their detail anatomical structure, histological features
and electrophysiological behavior are signiﬁcant to clear the complex
conduction characteristics of the AV junction.
METHODS Adult rats(n¼6), mice(n¼5) and rabbit(n¼5) were used.
Serial sections from the entire AV junction were obtained. Masson’s
trichrome stain was performed on AVN regions to assess for ﬁbrous
tissue. Three connexins(Cx) proteins including Cx43, Cx40 and Cx45
which dominate the electronic conduction of the heart and three main
ion channels(Nav1.5, Cav3.1 and HCN4) participating the depolariza-
tion of myocardial cell were immunohistochemically labeled. Serial
sections were used to reconstruct a 3D computational model of the
anatomy of the AV junction which display the different histological
features at different levels.
RESULTS There appears to be an anterior extension of the AVN which
connect retroaortic node and AVN. The anterior node extension
(ANE), compact node and INE express the same connexin isoforms.
Nav1.5 labeling was abundant in the atrial and ventricular myocar-
dium. Nav1.5 labeling presents at a reduced level in the compact node,
ANE and INE. Cav3.1 and HCN4 expression were mainly expressed in
the Nav1.5 reduced area. Further, connections between the atria and
inferior extension occur indirectly via small branches. However, this
was distinct from the connection pattern that we observed between
the atria and ANE, which was direct.
CONCLUSIONS We conclude that the retroaortic node connect with
ANE forming ANE which suggests there would be direct electric con-
duction between them. Characteristics of these structures are
conserved among various species including rat, mouse and rabbit as
we had proven. ANE, AVN and INE have nearly the same electronic
level and action potential level structure basic that highlight they
would have the same conduction properties, but there are different
connection patterns in atrium between them that suggests there
would be the subtle conduction velocity difference after accept the
impulse, which provide a new location and substrate of conduction
that may present new insights on mechanisms underlying normal AV
conduction and AVNRT.
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OBJECTIVES AVE 0991, the nonpeptide angiotensin-(1-7) (Ang-(1-7))
analog, is recognized as having beneﬁcial cardiovascular effects.
However, the mechanisms have not been fully elucidated. This study
was designed to investigate the effects of AVE 0991 on cardiac hy-
pertrophy and the mechanisms involved.
METHODS Mice were subjected to aortic banding (AB) to induce cardiac
hypertrophy. After treatment with AVE 0991 (20 mg$kg$day (-1)) for four
weeks, indices of cardiac hypertrophy and heart function were
measured by echocardiography, histological analyses and quantitative
